1-20 of 33
Wei Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Cell Sequencing Analysis Reveals Cellular Dynamics Underlying Different Responses to Blinatumomab in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Mingying Zhang, Yuanyuan Zhang, Peijing Qi, Wei Lin, Ying Wu, Jiaole Yu, Huyong Zheng, Ruidong Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4214.
https://doi.org/10.1182/blood-2024-204307
Published: 2024
Journal Articles

Inequalities in Treatment Utilization Among Older Medicare Beneficiaries with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Induction Therapy

Amer M. Zeidan, Yanqing Xu, Tatyana A. Kapustyan, Kaylee Miu, Cheng Chen, Rajesh Kamalakar, Chia-Wei Lin, Esprit Ma, Melissa Montez, Zheng Wu, Tracy Yee, Haiyan Sun, Andrew Rava, Sonia Kim, Scott F Huntington
Journal: Blood
Blood (2024) 144 (Supplement 1): 3795.
https://doi.org/10.1182/blood-2024-200213
Published: 2024
Journal Articles

Full-Spectrum Flow Cytometry Analysis Reveals Dynamics of T Cell Function of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia during Continuous Infusion of Blinatumomab

Mingying Zhang, Yuanyuan Zhang, Peijing Qi, Wei Lin, Ying Wu, Jiaole Yu, Huyong Zheng, Ruidong Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 5922.
https://doi.org/10.1182/blood-2024-209220
Published: 2024
Journal Articles

Efficacy and Safety of Adding Blinatumomab to First-Line Treatment for Chinese Children with B-Cell Acute Lymphoblastic Leukemia

Peijing Qi, Yuanyuan Zhang, Ying Wu, Jiaole Yu, Jia Fan, Wei Lin, Huyong Zheng, Ruidong Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 312.
https://doi.org/10.1182/blood-2024-199937
Published: 2024
Journal Articles

Cost-Effectiveness of Emicizumab Vs Efanesoctocog Alfa, Standard Half Life (SHL) and Other Extended Half Life (EHL) FVIII Products for Prophylaxis in People with Severe Hemophilia a without Inhibitors

Randall Curtis, Marquita Decker-Palmer, Michele R Wilson, Cheryl L McDade, Chia-Wei Lin, Chris Wallick, Richard H Ko
Journal: Blood
Blood (2023) 142 (Supplement 1): 5053.
https://doi.org/10.1182/blood-2023-181062
Published: 2023
Journal Articles

Cost-Effectiveness of Emicizumab for Prophylaxis in People with Severe Hemophilia A without Inhibitors

Marquita Decker-Palmer, Chia-Wei Lin, Michele Wilson, Cheryl McDade, Komal Bawa, Stacey Kowal, Arliene Ravelo, Elaine Yu, Richard H. Ko
Journal: Blood
Blood (2022) 140 (Supplement 1): 13041–13042.
https://doi.org/10.1182/blood-2022-162276
Published: 2022
Journal Articles

Patient-Reported Outcomes Among Adults with Hemophilia A on Prophylactic Treatment

Janet Chupka, Marquita Decker-Palmer, Chia-Wei Lin, Ashley Martin, Kushal Modi, Dawn Bates, Karen Thomson
Journal: Blood
Blood (2022) 140 (Supplement 1): 10893–10894.
https://doi.org/10.1182/blood-2022-159064
Published: 2022
Journal Articles

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Jing Li, Ju Gao, Ansheng Liu, Wei Liu, Hao Xiong, Changda Liang, Yongjun Fang, Yunpeng Dai, Jingbo Shao, Hui Yu, Lingzhen Wang, Li Wang, Liangchun Yang, Mei Yan, Xiaowen Zhai, Xiaodong Shi, Xin Tian, Xiuli Ju, Yan Chen, Jing Wang, Leping Zhang, Hui Liang, Sen Chen, Jingrong Zhang, Haixia Cao, Jiao Jin, Qun Hu, Junlan Wang, Yilin Wang, Min Zhou, Yueqin Han, Rong Zhang, Weihong Zhao, Aimin Li, Limin Lin, Ruidong Zhang, Chao Gao, Liting Xu, Yuanyuan Zhang, Jia Fan, Ying Wu, Wei Lin, Jiaole Yu, Peijing Qi, Pengli Huang, Xiaoxia Peng, Yaguang Peng, Huyong Zheng
Journal: Blood
Blood (2022) 140 (Supplement 1): 3189–3191.
https://doi.org/10.1182/blood-2022-165737
Published: 2022
Journal Articles

E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia

Wen-Chieh Pi, Jun Wang, Miho Shimada, Jia-Wei Lin, Huimin Geng, Yu-Ling Lee, Rui Lu, Dongxu Li, Gang Greg Wang, Robert G. Roeder, Wei-Yi Chen
Journal: Blood
Blood (2020) 136 (1): 11–23.
https://doi.org/10.1182/blood.2019003312
Published: 2020
Includes: Supplemental data
Journal Articles

A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As a Single Agent in Relapsed or Refractory Hematologic Malignancies and in Combination with Daratumumab As a Salvage Regimen for Multiple Myeloma

Nina D. Shah, MD, Cameron J. Turtle, MBBS, PhD, Andrew J. Cowan, MD, Julio C. Chavez, MD, Lihua E Budde, MD PhD, Mario Q. Marcondes, MD PhD, Zachary Lee, PharmD, Wei Lin, MD, Jonathan Zalevsky, Mary Tagliaferri, MD, Krina K. Patel, MDMSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 4459.
https://doi.org/10.1182/blood-2019-122494
Published: 2019
Journal Articles

Pilot Study on the Safety of Intravenous Arsenic Trioxide and Oral Realgar-Indigo Naturalis Formula Administrated in Children with Acute Promyelocytic Leukemia: A Single-Center Study

Linya Wang, MD, Yuanyuan Zhang, MD, Ruidong Zhang, MD PhD, Jiaole Yu, PhD MD, Ying Wu, MD, Wei Lin, Peijing Qi, Jia Fan, Jing Li, PhD, Jiayan Lin, Xueling Zheng, Hairu Hu, Xiaoxia Peng, Hui Jiang, PhD, Huyong Zheng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2611.
https://doi.org/10.1182/blood-2019-128196
Published: 2019
Journal Articles

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Yuan Li, MD, Qing Ya Wang, MD, Ze Yin Liang, Yue Yin, Wei Liu, MD PhD, Qian Wang, Yujun Dong, MD, YuHua Sun, Wei Lin Xu, Hanyun Ren, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5647.
https://doi.org/10.1182/blood-2019-125275
Published: 2019
Journal Articles

Clinical Characteristics & Outcome of Adolescent Patients with Acute Lymphoblastic Leukemia

Jiaole Yu, PhD MD, Ruidong Zhang, MD PhD, Jing Xie, MD, Yuanyuan Zhang, MD, Ying Wu, MD, Chao Gao, Wei Lin, Huyong Zheng, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5007.
https://doi.org/10.1182/blood.V130.Suppl_1.5007.5007
Published: 2017
Journal Articles

Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma

Chia-Jen Liu, MD, Pei Hsu, MD, Ting-Wei Lin, MD, Jyh-Pyng Gau, MD, Liang-Tsai Hsiao, MD, Cheng-Hwai Tzeng, MD, Po-Min Chen, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Yao-Chung Liu, MD, Jing-Hwang Liu, MD
Journal: Blood
Blood (2015) 126 (23): 5306.
https://doi.org/10.1182/blood.V126.23.5306.5306
Published: 2015
Journal Articles

Manumycin Induces Apoptosis of Leukemic Stem Cells Through Down-Regulation of Bcl2

Miaorong She, Jinggao Li, Xilin Chen, Xin Du, PhD, Wei Lin, Zesheng Lu, Yanjie He, Kunyuan Guo
Journal: Blood
Blood (2011) 118 (21): 4738.
https://doi.org/10.1182/blood.V118.21.4738.4738
Published: 2011
Journal Articles

Human γδ T lymphocytes induce robust NK cell–mediated antitumor cytotoxicity through CD137 engagement

Amudhan Maniar, Xiaoyu Zhang, Wei Lin, Brian R. Gastman, C. David Pauza, Scott E. Strome, Andrei I. Chapoval
Journal: Blood
Blood (2010) 116 (10): 1726–1733.
https://doi.org/10.1182/blood-2009-07-234211
Published: 2010
Includes: Supplemental data
Journal Articles

A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma

Ying-Wei Lin, Zanna M. Beharry, Elizabeth G. Hill, Jin H. Song, Wenxue Wang, Zuping Xia, Zhenhua Zhang, Peter D. Aplan, Jon C. Aster, Charles D. Smith, Andrew S. Kraft
Journal: Blood
Blood (2010) 115 (4): 824–833.
https://doi.org/10.1182/blood-2009-07-233445
Published: 2010
Includes: Supplemental data
Journal Articles

Analysis of Clinical Characterization of CMML.

Suijing Wu, MD, Xin Du, PhD, Wei Lin, Zilun Huang, Jianyu Weng, MD, Zhixin Huang, Maohua Zhou, MD, Jianhua Su, Zesheng Lu
Journal: Blood
Blood (2009) 114 (22): 4853.
https://doi.org/10.1182/blood.V114.22.4853.4853
Published: 2009
Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang
Journal: Blood
Blood (2009) 114 (22): 1147.
https://doi.org/10.1182/blood.V114.22.1147.1147
Published: 2009
Journal Articles

Fc-dependent expression of CD137 on human NK cells: insights into “agonistic” effects of anti-CD137 monoclonal antibodies

Wei Lin, Caroline J. Voskens, Xiaoyu Zhang, Daniel G. Schindler, Aaron Wood, Erin Burch, Yadong Wei, Lieping Chen, Guoliang Tian, Koji Tamada, Lai-Xi Wang, Dan H. Schulze, Dean Mann, Scott E. Strome
Journal: Blood
Blood (2008) 112 (3): 699–707.
https://doi.org/10.1182/blood-2007-11-122465
Published: 2008